Overexpression of IL-6 has been found in most cancer types, particularly NSCLC (62, 63), and has been shown to have an inverse correlation with patient prognosis (64, 65) and higher resistance to chemotherapy (66). This evidence concerns the gene IL6 and non-small cell lung carcinoma.